beta blocker: be used in angina

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be used in angina 1.00
be contraindicated in angina 0.91
be contraindicated in vasospastic angina 0.91
be used in hypertension 0.85
be called hypertension 0.83
be contraindicated in patients with asthma 0.82
be contraindicated in asthma 0.80
be contraindicated with asthma 0.80
be bad for asthma 0.80
be used for migraines 0.79

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.53
Rule weight: 0.66
Evidence weight: 0.96
Similarity weight: 0.83
Evidence: 0.89
Plausible(high blood pressure, be called hypertension) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in angina)

Plausibility inheritance from parent to child

0.04
Rule weight: 0.09
Evidence weight: 0.52
Similarity weight: 0.83
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.89
¬ Plausible(high blood pressure, be called hypertension)

Remarkability exclusitivity betweem a parent and a child

0.25
Rule weight: 0.58
Evidence weight: 0.51
Similarity weight: 0.83
Evidence: 0.85
¬ Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.57
¬ Remarkable(high blood pressure, be called hypertension)

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.45
Similarity weight: 0.80
Evidence: 0.85
¬ Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.65
¬ Remarkable(atenolol, be contraindicated in asthma)

Remarkability from parent implausibility

0.35
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.83
Evidence: 0.89
Plausible(high blood pressure, be called hypertension) ⋁
Evidence: 0.85
Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.46
¬ Plausible(beta blocker, be used in angina)

Remarkability from sibling implausibility

0.41
Rule weight: 0.60
Evidence weight: 0.86
Similarity weight: 0.80
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.65
Remarkable(atenolol, be contraindicated in asthma) ⋁
Evidence: 0.75
¬ Plausible(atenolol, be contraindicated in asthma)

Salient implies Plausible

0.18
Rule weight: 0.28
Evidence weight: 0.65
Similarity weight: 1.00
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.65
¬ Salient(beta blocker, be used in angina)

Similarity expansion

0.71
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.91
Evidence: 0.85
Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.64
¬ Remarkable(beta blocker, be contraindicated in vasospastic angina)
0.63
Rule weight: 0.85
Evidence weight: 0.87
Similarity weight: 0.85
Evidence: 0.85
Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.87
¬ Remarkable(beta blocker, be used in hypertension)
0.63
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.82
Evidence: 0.85
Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.67
¬ Remarkable(beta blocker, be contraindicated in patients with asthma)
0.62
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.80
Evidence: 0.85
Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.57
¬ Remarkable(beta blocker, be bad for asthma)
0.62
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.80
Evidence: 0.85
Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.68
¬ Remarkable(beta blocker, be contraindicated with asthma)
0.61
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.80
Evidence: 0.85
Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.77
¬ Remarkable(beta blocker, be contraindicated in asthma)
0.61
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.79
Evidence: 0.85
Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.68
¬ Remarkable(beta blocker, be used for migraines)
0.57
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.91
Evidence: 0.65
Salient(beta blocker, be used in angina) ⋁
Evidence: 0.79
¬ Salient(beta blocker, be contraindicated in vasospastic angina)
0.55
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.85
Evidence: 0.34
Typical(beta blocker, be used in angina) ⋁
Evidence: 0.36
¬ Typical(beta blocker, be used in hypertension)
0.55
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.85
Evidence: 0.65
Salient(beta blocker, be used in angina) ⋁
Evidence: 0.70
¬ Salient(beta blocker, be used in hypertension)
0.53
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.85
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.49
¬ Plausible(beta blocker, be used in hypertension)
0.52
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.80
Evidence: 0.65
Salient(beta blocker, be used in angina) ⋁
Evidence: 0.66
¬ Salient(beta blocker, be bad for asthma)
0.50
Rule weight: 0.85
Evidence weight: 0.72
Similarity weight: 0.80
Evidence: 0.65
Salient(beta blocker, be used in angina) ⋁
Evidence: 0.79
¬ Salient(beta blocker, be contraindicated with asthma)
0.49
Rule weight: 0.85
Evidence weight: 0.73
Similarity weight: 0.79
Evidence: 0.65
Salient(beta blocker, be used in angina) ⋁
Evidence: 0.77
¬ Salient(beta blocker, be used for migraines)
0.49
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.82
Evidence: 0.65
Salient(beta blocker, be used in angina) ⋁
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in patients with asthma)
0.49
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.80
Evidence: 0.65
Salient(beta blocker, be used in angina) ⋁
Evidence: 0.84
¬ Salient(beta blocker, be contraindicated in asthma)
0.48
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.91
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.70
¬ Plausible(beta blocker, be contraindicated in vasospastic angina)
0.45
Rule weight: 0.85
Evidence weight: 0.67
Similarity weight: 0.80
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.61
¬ Plausible(beta blocker, be bad for asthma)
0.43
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.80
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.69
¬ Plausible(beta blocker, be contraindicated with asthma)
0.43
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.80
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.69
¬ Plausible(beta blocker, be contraindicated in asthma)
0.43
Rule weight: 0.85
Evidence weight: 0.63
Similarity weight: 0.79
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.68
¬ Plausible(beta blocker, be used for migraines)
0.40
Rule weight: 0.85
Evidence weight: 0.57
Similarity weight: 0.82
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in patients with asthma)
0.40
Rule weight: 0.85
Evidence weight: 0.51
Similarity weight: 0.91
Evidence: 0.34
Typical(beta blocker, be used in angina) ⋁
Evidence: 0.74
¬ Typical(beta blocker, be contraindicated in vasospastic angina)
0.38
Rule weight: 0.85
Evidence weight: 0.55
Similarity weight: 0.80
Evidence: 0.34
Typical(beta blocker, be used in angina) ⋁
Evidence: 0.67
¬ Typical(beta blocker, be contraindicated in asthma)
0.38
Rule weight: 0.85
Evidence weight: 0.56
Similarity weight: 0.80
Evidence: 0.34
Typical(beta blocker, be used in angina) ⋁
Evidence: 0.66
¬ Typical(beta blocker, be bad for asthma)
0.37
Rule weight: 0.85
Evidence weight: 0.54
Similarity weight: 0.79
Evidence: 0.34
Typical(beta blocker, be used in angina) ⋁
Evidence: 0.69
¬ Typical(beta blocker, be used for migraines)
0.36
Rule weight: 0.85
Evidence weight: 0.52
Similarity weight: 0.80
Evidence: 0.34
Typical(beta blocker, be used in angina) ⋁
Evidence: 0.72
¬ Typical(beta blocker, be contraindicated with asthma)
0.32
Rule weight: 0.85
Evidence weight: 0.46
Similarity weight: 0.82
Evidence: 0.34
Typical(beta blocker, be used in angina) ⋁
Evidence: 0.82
¬ Typical(beta blocker, be contraindicated in patients with asthma)

Typical and Remarkable implies Salient

0.12
Rule weight: 0.14
Evidence weight: 0.90
Similarity weight: 1.00
Evidence: 0.65
Salient(beta blocker, be used in angina) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in angina) ⋁
Evidence: 0.85
¬ Remarkable(beta blocker, be used in angina)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.82
Similarity weight: 1.00
Evidence: 0.46
Plausible(beta blocker, be used in angina) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in angina)

Typicality and Rermarkability incompatibility between a parent and a child

0.09
Rule weight: 0.51
Evidence weight: 0.20
Similarity weight: 0.83
Evidence: 0.85
¬ Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.94
¬ Typical(high blood pressure, be called hypertension)

Typicality and Rermarkability incompatibility between siblings

0.04
Rule weight: 0.14
Evidence weight: 0.33
Similarity weight: 0.80
Evidence: 0.85
¬ Remarkable(beta blocker, be used in angina) ⋁
Evidence: 0.79
¬ Typical(atenolol, be contraindicated in asthma)

Typicality inheritance from parent to child

0.15
Rule weight: 0.48
Evidence weight: 0.38
Similarity weight: 0.83
Evidence: 0.34
Typical(beta blocker, be used in angina) ⋁
Evidence: 0.94
¬ Typical(high blood pressure, be called hypertension)